Home | Screening data | Screen comparisons | Search for compounds | Structure search

Compound InformationSONAR Target prediction
Name:

Carbamazepine

Unique Identifier:LOPAC 00496
MolClass: Checkout models in ver1.5 and ver1.0
Molecular Formula:C15H12N2O
Molecular Weight:224.173 g/mol
X log p:20.464  (online calculus)
Lipinksi Failures1
TPSA20.31
Hydrogen Bond Donor Count:0
Hydrogen Bond Acceptors Count:3
Rotatable Bond Count:1
Canonical Smiles:NC(=O)N1c2ccccc2C=Cc2ccccc12
Class:Anticonvulsant
Generic_name:Carbamazepine
Chemical_iupac_name:5H-dibenz[b,f]azepine-5-carboxamide
Drug_type:Approved Drug
Kegg_compound_id:C06868
Drugbank_id:APRD00337
Melting_point:190.2 oC
H2o_solubility:17.7 mg/L
Logp:2.69
Cas_registry_number:298-46-4
Mass_spectrum:http://webbook.nist.gov/cgi/cbook.cgi?Spec=C298464&Index=0&Type=Mass&Large=on
Drug_category:Analgesics; Antimanic Agents; Anticonvulsants; ATC:N03AF01
Indication:For the treatment of epilepsy and pain associated with true trigeminal neuralgia.
Pharmacology:Carbamazepine, an anticonvulsant structurally similar to tricyclic antidepressants,
is used to treat partial seizures, tonic-clonic seizures, pain of neurologic origin
such as trigeminal neuralgia, and psychiatric disorders including manic-depressive
illness and aggression due to dementia.
Mechanism_of_action:Carbamazepine inhibits sustained repetitive firing by blocking use-dependent sodium
channels. Pain relief is believed to be associated with blockade of synaptic
transmission in the trigeminal nucleus and seizure control with reduction of
post-tetanic potentiation of synaptic transmission in the spinal cord. Carbamazepine
also possesses anticholinergic, central antidiuretic, antiarrhythmic, muscle
relaxant, antidepressant (possibly through blockade of norepinephrine release),
sedative, and neuromuscular-blocking properties.
Organisms_affected:Humans and other mammals

Found: 24 nonactive as graph: single | with analogs [1] << Back 1 2 3 4 5 6 7 8 9 10  Next >> [24]
Species: 4932
Condition: CIN2
Replicates: 2
Raw OD Value: r im 0.8423±0.00325269
Normalized OD Score: sc h 1.0058±0.00521458
Z-Score: 0.4587±0.440362
p-Value: 0.662044
Z-Factor: -24.135
Fitness Defect: 0.4124
Bioactivity Statement: Nonactive
Experimental Conditions
Library:Lopac
Plate Number and Position:4|F3
Drug Concentration:50.00 nM
OD Absorbance:600 nm
Robot Temperature:26.90 Celcius
Date:2005-12-07 YYYY-MM-DD
Plate CH Control (+):0.039025000000000004±0.00114
Plate DMSO Control (-):0.8283499999999999±0.01004
Plate Z-Factor:0.9451
png
ps
pdf

DBLink | Rows returned: 2
2554
158856

internal high similarity DBLink | Rows returned: 1
SPE01500159 1.0000

active | Cluster 6146 | Additional Members: 5 | Rows returned: 0

Service provided by the Mike Tyers Laboratory